Results from a Phase II, randomized, double-blind, placebo-controlled, dose-ranging trial designed to evaluate the efficacy and safety of brodalumab (formerly AMG 827) in 198 patients with moderate to severe plaque psoriasis have been published in the …
Immunological diseases, such as eczema and asthma, are on the increase in westernised society and represent a major challenge for 21st century medicine. A new study has shown, for the first time, that growing up on a farm directly affects the regulatio…
Scientists have found that a strain of yeast implicated in inflammatory skin conditions, including eczema, can be killed by certain peptides and could potentially provide a new treatment for these debilitating skin conditions. This research is publishe…
Scientists in Sweden have discovered certain peptides kill off the yeast Malassezia sympodialis which can trigger skin disorders such as atopic eczema, seborrhoeic eczema, and dandruff, without harming healthy skin cells. While further work is neede…
Among patients with moderate to severe psoriasis, treatment options that are most compatible with their personal and professional life appear to be most important, and treatment location appears matter more than probability and magnitude of treatment o…
Collaborative research from Perelman School of Medicine at the University of Pennsylvania has shown that psoriasis patients have an increased risk of heart attack, stroke and cardiovascular death, especially if the psoriasis is moderate to severe. Now,…
At the annual European Academy of Dermatology and Venereology (EADV) Congress in Lisbon, Portugal, Novartis announced positive results from its three Phase II trials of AIN457 (secukinumab), a drug designed for the treatment of psoriasis. The results r…
The outer layer of the skin, called the epidermis, forms a critical physical and immunological wall that serves as the body’s first line of defense against potentially harmful microorganisms. Most of the epidermis consists of cells called keratinocytes…
There is no compelling evidence to link some psoriasis medications with major adverse cardiovascular events, despite a number of preliminary reports that appeared to indicate so, researchers from the Baylor Research Institute, Dallas, Texas reported in…
The largest worldwide study on the association between breastfeeding, time of weaning and eczema in children has concluded that there is no clear evidence that exclusive breastfeeding for four months or longer protects against childhood eczema The larg…
